Eli Lilly is hoping to make an even more potent drug than Zepbound by adding a third mechanism involved in weight loss
However, when kidney function becomes compromised, this safety profile changes dramatically, making it worth having a deeper conversation with your healthcare provider
Some people might never fully recover their functionality if they sustain chronic injury (Tan and Song 2023)
Patients taking GLP-1 therapy often have underlying conditions such as obesity and diabetes that independently increase thrombotic risk
The researchers emphasized that most of the observed improvements were modest and primarily linked to weight loss, benefiting mainly diabetics and those who are overweight
You can choose to set up a subscription, which includes discounted pricing, our loyalty program and several other benefits or you can place a one-time order of a curated box